Dow Down 0.18% Nasdaq Up 0.39%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.30 Up 1.26(2.42%) 4:00PM EDT
|After Hours : 53.00 Down 0.30 (0.56%) 4:01PM EDT
Prev Close:52.04
Open:52.71
Bid:52.90 x 100
Ask:53.36 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:52.56 - 53.74
52wk Range:39.75 - 80.42
Volume:356,640
Avg Vol (3m):392,280
Market Cap:1.11B
P/E (ttm):91.42
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 2.42%1.11B
LLYUp 0.19%68.25B
MRKDown 0.53%172.47B
RHHBYUp 0.14%248.42B

Key Statistics

Forward P/E (1 yr):21.93
P/S (ttm):19.91
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback